The latest study on Biosimilar Testing and Development Services Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Biosimilar Testing and Development Services Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Biosimilar Testing and Development Services and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Biosimilar Testing and Development Services Market Analysis By Type Segment:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Biosimilar Testing and Development Services Market Analysis By Application Segment:
PK assay
Tiered Immunogenicity testing
NAb assays
Biosimilar Testing and Development Services Market Analysis By Regions (Countries):
The Biosimilar Testing and Development Services Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Biosimilar Testing and Development Services Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Biosimilar Testing and Development Services Market:
Biosimilar Testing and Development Services market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Biosimilar Testing and Development Services Market status and future forecast.
To present the key Biosimilar Testing and Development Services Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (2016-2027)
1.4.2 Effector Binding
1.4.3 ELISA
1.4.4 Kinetic Binding Assays
1.4.5 ADCC & CDC Cell-Based Assays
1.5 Market by Application
1.5.1 Global Biosimilar Testing and Development Services Market Share by Application (2016-2027)
1.5.2 PK assay
1.5.3 Tiered Immunogenicity testing
1.5.4 NAb assays
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biosimilar Testing and Development Services Market Size
2.2 Biosimilar Testing and Development Services Growth Trends by Regions
2.2.1 Biosimilar Testing and Development Services Market Size by Regions (2016-2027)
2.2.2 Biosimilar Testing and Development Services Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Biosimilar Testing and Development Services Market Size by Manufacturers
3.1.1 Global Biosimilar Testing and Development Services Revenue by Manufacturers (2020)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Manufacturers (2020)
3.1.3 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.3 Key Players Biosimilar Testing and Development Services Product/Solution/Service
3.4 Date of Enter into Biosimilar Testing and Development Services Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Biosimilar Testing and Development Services Market Size by Type (2016-2020)
4.2 Global Biosimilar Testing and Development Services Market Size by Application (2016-2020)
5 United States
5.1 United States Biosimilar Testing and Development Services Market Size (2016-2020)
5.2 Biosimilar Testing and Development Services Key Players in United States
5.3 United States Biosimilar Testing and Development Services Market Size by Type
5.4 United States Biosimilar Testing and Development Services Market Size by Application
6 Europe
6.1 Europe Biosimilar Testing and Development Services Market Size (2016-2020)
6.2 Biosimilar Testing and Development Services Key Players in Europe
6.3 Europe Biosimilar Testing and Development Services Market Size by Type
6.4 Europe Biosimilar Testing and Development Services Market Size by Application
7 China
7.1 China Biosimilar Testing and Development Services Market Size (2016-2020)
7.2 Biosimilar Testing and Development Services Key Players in China
7.3 China Biosimilar Testing and Development Services Market Size by Type
7.4 China Biosimilar Testing and Development Services Market Size by Application
8 Japan
8.1 Japan Biosimilar Testing and Development Services Market Size (2016-2020)
8.2 Biosimilar Testing and Development Services Key Players in Japan
8.3 Japan Biosimilar Testing and Development Services Market Size by Type
8.4 Japan Biosimilar Testing and Development Services Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Biosimilar Testing and Development Services Market Size (2016-2020)
9.2 Biosimilar Testing and Development Services Key Players in Southeast Asia
9.3 Southeast Asia Biosimilar Testing and Development Services Market Size by Type
9.4 Southeast Asia Biosimilar Testing and Development Services Market Size by Application
10 India
10.1 India Biosimilar Testing and Development Services Market Size (2016-2020)
10.2 Biosimilar Testing and Development Services Key Players in India
10.3 India Biosimilar Testing and Development Services Market Size by Type
10.4 India Biosimilar Testing and Development Services Market Size by Application
11 Central & South America
11.1 Central & South America Biosimilar Testing and Development Services Market Size (2016-2020)
11.2 Biosimilar Testing and Development Services Key Players in Central & South America
11.3 Central & South America Biosimilar Testing and Development Services Market Size by Type
11.4 Central & South America Biosimilar Testing and Development Services Market Size by Application
12 International Players Profiles
12.1 Eurofins Scientific
12.1.1 Eurofins Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilar Testing and Development Services Introduction
12.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2020)
12.1.5 Eurofins Scientific Recent Development
12.2 SGS
12.2.1 SGS Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilar Testing and Development Services Introduction
12.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2020)
12.2.5 SGS Recent Development
12.3 Charles River Laboratories
12.3.1 Charles River Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilar Testing and Development Services Introduction
12.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2020)
12.3.5 Charles River Laboratories Recent Development
12.4 Pharmaceutical Product Development
12.4.1 Pharmaceutical Product Development Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilar Testing and Development Services Introduction
12.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2020)
12.4.5 Pharmaceutical Product Development Recent Development
12.5 Exova
12.5.1 Exova Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilar Testing and Development Services Introduction
12.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2020)
12.5.5 Exova Recent Development
12.6 Source BioScience
12.6.1 Source BioScience Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilar Testing and Development Services Introduction
12.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2020)
12.6.5 Source BioScience Recent Development
12.7 Intertek Group
12.7.1 Intertek Group Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilar Testing and Development Services Introduction
12.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2020)
12.7.5 Intertek Group Recent Development
12.8 Medistri
12.8.1 Medistri Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilar Testing and Development Services Introduction
12.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2020)
12.8.5 Medistri Recent Development
12.9 Pace Analytical Services
12.9.1 Pace Analytical Services Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilar Testing and Development Services Introduction
12.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2020)
12.9.5 Pace Analytical Services Recent Development
12.10 Sigma-Aldrich
12.10.1 Sigma-Aldrich Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biosimilar Testing and Development Services Introduction
12.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2020)
12.10.5 Sigma-Aldrich Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Biosimilar Testing and Development Services Key Market Segments
Table Key Players Biosimilar Testing and Development Services Covered
Table Global Biosimilar Testing and Development Services Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Biosimilar Testing and Development Services Market Size Market Share by Type 2016-2027
Figure Effector Binding Figures
Table Key Players of Effector Binding
Figure ELISA Figures
Table Key Players of ELISA
Figure Kinetic Binding Assays Figures
Table Key Players of Kinetic Binding Assays
Figure ADCC & CDC Cell-Based Assays Figures
Table Key Players of ADCC & CDC Cell-Based Assays
Table Global Biosimilar Testing and Development Services Market Size Growth by Application 2016-2027 (Million US$)
Figure PK assay Case Studies
Figure Tiered Immunogenicity testing Case Studies
Figure NAb assays Case Studies
Figure Biosimilar Testing and Development Services Report Years Considered
Table Global Biosimilar Testing and Development Services Market Size 2016-2027 (Million US$)
Figure Global Biosimilar Testing and Development Services Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Biosimilar Testing and Development Services Market Size by Regions 2016-2027 (Million US$)
Table Global Biosimilar Testing and Development Services Market Size by Regions 2016-2020 (Million US$)
Table Global Biosimilar Testing and Development Services Market Share by Regions 2016-2020
Figure Global Biosimilar Testing and Development Services Market Share by Regions 2016-2020
Figure Global Biosimilar Testing and Development Services Market Share by Regions 2020
Table Market Top Trends
Table Global Biosimilar Testing and Development Services Revenue by Manufacturers (2020) (Million US$)
Table Global Biosimilar Testing and Development Services Market Share by Manufacturers (2020)
Figure Global Biosimilar Testing and Development Services Market Share by Manufacturers in 2020
Table Global Biosimilar Testing and Development Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biosimilar Testing and Development Services Product/Solution/Service
Table Date of Enter into Biosimilar Testing and Development Services Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table Global Biosimilar Testing and Development Services Market Size Share by Type (2016-2020)
Figure Global Biosimilar Testing and Development Services Market Size Market Share by Type (2016-2020)
Table Global Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table Global Biosimilar Testing and Development Services Market Size Share by Application (2016-2020)
Figure Global Biosimilar Testing and Development Services Market Size Market Share by Application (2016-2020)
Figure Global Biosimilar Testing and Development Services Revenue Market Share by Application in 2020
Figure United States Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table United States Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table United States Key Players Biosimilar Testing and Development Services Market Share (2020)
Table United States Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table United States Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table United States Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table United States Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Figure Europe Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table Europe Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table Europe Key Players Biosimilar Testing and Development Services Market Share (2020)
Table Europe Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table Europe Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table Europe Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table Europe Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Figure China Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table China Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table China Key Players Biosimilar Testing and Development Services Market Share (2020)
Table China Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table China Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table China Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table China Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Figure Japan Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table Japan Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table Japan Key Players Biosimilar Testing and Development Services Market Share (2020)
Table Japan Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table Japan Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table Japan Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table Japan Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Figure Southeast Asia Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table Southeast Asia Key Players Biosimilar Testing and Development Services Market Share (2020)
Table Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Figure India Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table India Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table India Key Players Biosimilar Testing and Development Services Market Share (2020)
Table India Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table India Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table India Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table India Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Figure Central & South America Biosimilar Testing and Development Services Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Biosimilar Testing and Development Services Revenue (2020) (Million US$)
Table Central & South America Key Players Biosimilar Testing and Development Services Market Share (2020)
Table Central & South America Biosimilar Testing and Development Services Market Size by Type (2016-2020) (Million US$)
Table Central & South America Biosimilar Testing and Development Services Market Share by Type (2016-2020)
Table Central & South America Biosimilar Testing and Development Services Market Size by Application (2016-2020) (Million US$)
Table Central & South America Biosimilar Testing and Development Services Market Share by Application (2016-2020)
Table Eurofins Scientific Company Details
Table Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2020) (Million US$)
Figure Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Eurofins Scientific Recent Development
Table SGS Company Details
Table SGS Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table SGS Recent Development
Table Charles River Laboratories Company Details
Table Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Charles River Laboratories Recent Development
Table Pharmaceutical Product Development Company Details
Table Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Pharmaceutical Product Development Recent Development
Table Exova Company Details
Table Exova Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Exova Recent Development
Table Source BioScience Company Details
Table Source BioScience Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Source BioScience Recent Development
Table Intertek Group Company Details
Table Intertek Group Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Intertek Group Recent Development
Table Medistri Company Details
Table Medistri Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Medistri Recent Development
Table Pace Analytical Services Company Details
Table Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Pace Analytical Services Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2020)(Million US$)
Figure Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2020)
Table Sigma-Aldrich Recent Development
Table Global Biosimilar Testing and Development Services Market Size by Regions (Million US$) 2021-2027
Figure Global Biosimilar Testing and Development Services Market Size Share by Regions (2021-2027)
Figure Global Biosimilar Testing and Development Services Market Size Share by Regions in 2027
Figure United States Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Figure Europe Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Figure China Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Figure Japan Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Figure India Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Biosimilar Testing and Development Services Market Size Forecast (2021-2027)(Million USD)
Table Global Biosimilar Testing and Development Services Market Size by Product (2021-2027) (Million US$)
Figure Global Biosimilar Testing and Development Services Market Size by Product (2021-2027)
Figure Global Biosimilar Testing and Development Services Market Size by Product in 2027
Table Global Biosimilar Testing and Development Services Market Size by Application (2021-2027) (Million US$)
Figure Global Biosimilar Testing and Development Services Market Size by Application (2021-2027)
Figure Global Biosimilar Testing and Development Services Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources